Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q18392912> ?p ?o }
Showing triples 1 to 21 of
21
with 100 triples per page.
- Q18392912 subject Q20050944.
- Q18392912 subject Q8522216.
- Q18392912 abstract "RG7314 is a selective small molecule antagonist of the vasopressin V1A receptor which is under development by Roche for the treatment of autism. As of August 2014, it is in phase II clinical trials for this indication.".
- Q18392912 wikiPageExternalLink 800035102.
- Q18392912 wikiPageWikiLink Q14890024.
- Q18392912 wikiPageWikiLink Q1988322.
- Q18392912 wikiPageWikiLink Q20050944.
- Q18392912 wikiPageWikiLink Q21098891.
- Q18392912 wikiPageWikiLink Q212646.
- Q18392912 wikiPageWikiLink Q30612.
- Q18392912 wikiPageWikiLink Q38404.
- Q18392912 wikiPageWikiLink Q410943.
- Q18392912 wikiPageWikiLink Q7180990.
- Q18392912 wikiPageWikiLink Q8522216.
- Q18392912 type ChemicalSubstance.
- Q18392912 type Drug.
- Q18392912 type ChemicalObject.
- Q18392912 type Thing.
- Q18392912 type Q8386.
- Q18392912 comment "RG7314 is a selective small molecule antagonist of the vasopressin V1A receptor which is under development by Roche for the treatment of autism. As of August 2014, it is in phase II clinical trials for this indication.".
- Q18392912 label "RG7314".